Rajib Schubert is a biotech innovator working at the intersection of biology and technology, leading an NYU–KAIST program that transforms clinical insights into data-rich health-monitoring tools and novel therapies. His industry track record ranges from engineering antibody–drug conjugates at Immunomedics (acquired by Gilead) to heading Roche’s Sequencing Technologies division. He has also held leadership positions on the boards of the ETH Zürich Alumni Association and NextGenomics. When he’s not chasing breakthrough science with his team, Rajib enjoys mountain landscapes and appreciating art from around the world.

Office : E16(정문술빌딩) 1006호

Email: rajib.schubert@reversetranslationlab.com (preferred contact)

rajibs8@kaist.ac.kr

rs10115@nyu.edu 

Phone: +82 10-2118-7883

Official schedule(Google Calendar)

• Master’s student in Bio and Brain Engineering, KAIST (entered in 2025) 

• Studying functional genomics, long-read sequencing and neurological disease

• B.S. in biosystems and biomedical science, Korea University (graduated in 2025) 

• Love walking around and searching for decent resturants / cafe 😀

Email: jh.kim@reversetranslationlab.com

• Master’s student in Bio and Brain Engineering, KAIST (entered 2025) 

• Studying therapeutic protein engineering 

• B.A. in Home Economics Education and B.S. in Food Science, Korea University (graduated 2025) 

• Like to play tennis!

Email: bokyoung.cheong@reversetranslationlab.com

• Undergraduate student in Bio and Brain Engineering, KAIST (entered in 2022)

• Studying NGS-enabled health monitoring

• Like to play basketball and taking pictures

Email: gegeeneemns@reversetranslationlab.com

• Research scientist in Bio and Brain Engineering (entered in 2026)
• Studying therapeutic protein engineering
• M.S. in Genetic Engineering, Seoul National University (graduated in 2022)
• Like hiking!

Email: chaeyeon.park@reversetranslationlab.com